Cargando…

High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow

BACKGROUND: Cancer is a complex, multiscale dynamical system, with interactions between tumor cells and non-cancerous host systems. Therapies act on this combined cancer-host system, sometimes with unexpected results. Systematic investigation of mechanistic computational models can augment tradition...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozik, Jonathan, Collier, Nicholson, Wozniak, Justin M., Macal, Charles, Cockrell, Chase, Friedman, Samuel H., Ghaffarizadeh, Ahmadreza, Heiland, Randy, An, Gary, Macklin, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302449/
https://www.ncbi.nlm.nih.gov/pubmed/30577742
http://dx.doi.org/10.1186/s12859-018-2510-x
_version_ 1783381981883531264
author Ozik, Jonathan
Collier, Nicholson
Wozniak, Justin M.
Macal, Charles
Cockrell, Chase
Friedman, Samuel H.
Ghaffarizadeh, Ahmadreza
Heiland, Randy
An, Gary
Macklin, Paul
author_facet Ozik, Jonathan
Collier, Nicholson
Wozniak, Justin M.
Macal, Charles
Cockrell, Chase
Friedman, Samuel H.
Ghaffarizadeh, Ahmadreza
Heiland, Randy
An, Gary
Macklin, Paul
author_sort Ozik, Jonathan
collection PubMed
description BACKGROUND: Cancer is a complex, multiscale dynamical system, with interactions between tumor cells and non-cancerous host systems. Therapies act on this combined cancer-host system, sometimes with unexpected results. Systematic investigation of mechanistic computational models can augment traditional laboratory and clinical studies, helping identify the factors driving a treatment’s success or failure. However, given the uncertainties regarding the underlying biology, these multiscale computational models can take many potential forms, in addition to encompassing high-dimensional parameter spaces. Therefore, the exploration of these models is computationally challenging. We propose that integrating two existing technologies—one to aid the construction of multiscale agent-based models, the other developed to enhance model exploration and optimization—can provide a computational means for high-throughput hypothesis testing, and eventually, optimization. RESULTS: In this paper, we introduce a high throughput computing (HTC) framework that integrates a mechanistic 3-D multicellular simulator (PhysiCell) with an extreme-scale model exploration platform (EMEWS) to investigate high-dimensional parameter spaces. We show early results in applying PhysiCell-EMEWS to 3-D cancer immunotherapy and show insights on therapeutic failure. We describe a generalized PhysiCell-EMEWS workflow for high-throughput cancer hypothesis testing, where hundreds or thousands of mechanistic simulations are compared against data-driven error metrics to perform hypothesis optimization. CONCLUSIONS: While key notational and computational challenges remain, mechanistic agent-based models and high-throughput model exploration environments can be combined to systematically and rapidly explore key problems in cancer. These high-throughput computational experiments can improve our understanding of the underlying biology, drive future experiments, and ultimately inform clinical practice.
format Online
Article
Text
id pubmed-6302449
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63024492018-12-31 High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow Ozik, Jonathan Collier, Nicholson Wozniak, Justin M. Macal, Charles Cockrell, Chase Friedman, Samuel H. Ghaffarizadeh, Ahmadreza Heiland, Randy An, Gary Macklin, Paul BMC Bioinformatics Methodology BACKGROUND: Cancer is a complex, multiscale dynamical system, with interactions between tumor cells and non-cancerous host systems. Therapies act on this combined cancer-host system, sometimes with unexpected results. Systematic investigation of mechanistic computational models can augment traditional laboratory and clinical studies, helping identify the factors driving a treatment’s success or failure. However, given the uncertainties regarding the underlying biology, these multiscale computational models can take many potential forms, in addition to encompassing high-dimensional parameter spaces. Therefore, the exploration of these models is computationally challenging. We propose that integrating two existing technologies—one to aid the construction of multiscale agent-based models, the other developed to enhance model exploration and optimization—can provide a computational means for high-throughput hypothesis testing, and eventually, optimization. RESULTS: In this paper, we introduce a high throughput computing (HTC) framework that integrates a mechanistic 3-D multicellular simulator (PhysiCell) with an extreme-scale model exploration platform (EMEWS) to investigate high-dimensional parameter spaces. We show early results in applying PhysiCell-EMEWS to 3-D cancer immunotherapy and show insights on therapeutic failure. We describe a generalized PhysiCell-EMEWS workflow for high-throughput cancer hypothesis testing, where hundreds or thousands of mechanistic simulations are compared against data-driven error metrics to perform hypothesis optimization. CONCLUSIONS: While key notational and computational challenges remain, mechanistic agent-based models and high-throughput model exploration environments can be combined to systematically and rapidly explore key problems in cancer. These high-throughput computational experiments can improve our understanding of the underlying biology, drive future experiments, and ultimately inform clinical practice. BioMed Central 2018-12-21 /pmc/articles/PMC6302449/ /pubmed/30577742 http://dx.doi.org/10.1186/s12859-018-2510-x Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology
Ozik, Jonathan
Collier, Nicholson
Wozniak, Justin M.
Macal, Charles
Cockrell, Chase
Friedman, Samuel H.
Ghaffarizadeh, Ahmadreza
Heiland, Randy
An, Gary
Macklin, Paul
High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow
title High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow
title_full High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow
title_fullStr High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow
title_full_unstemmed High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow
title_short High-throughput cancer hypothesis testing with an integrated PhysiCell-EMEWS workflow
title_sort high-throughput cancer hypothesis testing with an integrated physicell-emews workflow
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302449/
https://www.ncbi.nlm.nih.gov/pubmed/30577742
http://dx.doi.org/10.1186/s12859-018-2510-x
work_keys_str_mv AT ozikjonathan highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT colliernicholson highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT wozniakjustinm highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT macalcharles highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT cockrellchase highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT friedmansamuelh highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT ghaffarizadehahmadreza highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT heilandrandy highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT angary highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow
AT macklinpaul highthroughputcancerhypothesistestingwithanintegratedphysicellemewsworkflow